George Golumbeski is Director at ENANTA PHARMACEUTICALS INC (ENTA). They have made 7 open-market trades across 3 companies since 2019, most recently 2026-06-03.
CIK 0001586660
3 open-market purchases totalling $650K since 2022, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SAGE | BUY | 2022-05-05 | 2022-05-09 | $31.45 | $252K | +9.5% | +29.1% | +47.9% |
| STTK | BUY | 2022-04-26 | 2022-04-27 | $3.63 | $206K | -12.2% | -29.4% | +8.3% |
| STTK | BUY | 2022-04-21 | 2022-04-26 | $3.69 | $193K | -8.8% | -25.6% | +16.8% |
| ENTA | SELL | 2019-03-04 | 2019-03-06 | $103.65 | $962K | +4.4% | -4.5% | -5.0% |
| ENTA | SELL | 2019-02-12 | 2019-02-13 | $90.07 | $1.0M | +6.9% | +5.9% | -8.7% |
| ENTA | SELL | 2019-02-11 | 2019-02-13 | $90.06 | $2.4M | +6.9% | +5.9% | -8.7% |
| ENTA | SELL | 2019-02-11 | 2019-02-13 | $90.03 | $205K | +6.9% | +5.9% | -8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.